Thank you for visiting our website. Our office is beginning to reopen, although our home office in San Bernardino is not fully staffed. The home office is open Monday – Thursday each week, and some Fridays We have employees working from home to answer your questions and our Consultants are available, as always. We are still conducting live webinars; please check the listings for dates and times. Please contact us at or leave a voicemail at (800) 399-6565. We will respond to your inquiries as soon as possible.


Avastin Reimbursement Change

CMS has reversed its instruction on the use of HCPCS code Q2024, with its gross underpayment, and instructed contractors to revert to the coding used prior to October 1, 2009. Any claims already paid...
Read more

Red Flag Rule Postponed Again

The Federal Trade Commission (FTC) has delayed the enforcement of the Red Flag Rule once again to June 1, 2010. The Red Flag Rule requires “creditors” to develop and implement a written identity theft...

Read more

2010 Medicare Deductible and Premiums

CMS announced in a press release published Friday, October 16, 2009 that the Medicare Part B deductible increases from $135 to $155 on January 1, 2010. In addition, the 2010 Part B premium remains unchanged...
Read more

New ICD-9 Codes effective October 1, 2009

The October 1 update of ICD-9 codes contains one new diagnosis code applicable to eye care physicians. The new code is:
  • 372.06 Acute chemical conjunctivitis
The new code is published in the 2010 ICD-9 coding manual....
Read more

New HCPCS Code for Bevacizumab (Avastin)

CMS announced the addition of a new HCPCS code for bevacizumab as of October 1, 2009. The new code reads:
  • Q2024 Injection, bevacizumab, 0.25 mg
Separate reimbursement for the drug will be made to physicians, ambulatory...
Read more

Website by MIC